Edition:
United Kingdom

China Traditional Chinese Medicine Holdings Co Ltd (0570.HK)

0570.HK on Hong Kong Stock

4.90HKD
7:35am GMT
Change (% chg)

HK$0.01 (+0.20%)
Prev Close
HK$4.89
Open
HK$4.82
Day's High
HK$4.98
Day's Low
HK$4.82
Volume
4,155,000
Avg. Vol
13,445,645
52-wk High
HK$7.57
52-wk Low
HK$4.21

Summary

Name Age Since Current Position

Xian Wu

51 2013 Executive Chairman of the Board

Min Situ

2017 Chief Financial Officer

He Huang

39 2018 Vice President

Zhangxin Huang

49 2013 Vice President

Qingsheng Zhang

57 2013 Vice President

Xiaochun Wang

49 2017 Managing Director, Executive Director

Wenming YANG

55 2018 Executive Director

Suet Lun Leung

2017 Joint Company Secretary

Dongji Zhao

50 2018 Joint Company Secretary

Kaipin Kui

33 2018 Non-Executive Director

Yan Rong

49 2018 Non-Executive Director

Kan WANG

34 2018 Non-Executive Director

Binghua YANG

38 2018 Non-Executive Director

Shanhua Yang

51 2018 Non-Executive Director

Wing Yat Lo

59 2015 Non-Executive Independent Director

Rong Xie

65 2013 Non-Executive Independent Director

Tze Shan Yu

62 2013 Independent Non-Executive Director

Bajun Zhou

67 2013 Non-Executive Independent Director

Eileen Wang

2015 Investor Relations Director

Biographies

Name Description

Xian Wu

Mr. Wu Xian has been appointed as Executive Chairman of the Board of Winteam Pharmaceutical Group Ltd., effective February 28, 2013. Mr. WU is the Chairman of the Board with effect from 28 February 2013. Mr. WU graduated from Shanxi College of Finance and Economics with a bachelor’s degree in economics in July 1985, and completed a master’s course in business administration from Harbin University of Commerce in September 2002. Mr. WU has over 29 years of production and financial management experience in pharmaceutical and healthcare products industry. Mr. WU was previously the head of the planning and development department of Harbin Pharmaceutical Group Co., Ltd., deputy plant manager of Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory and deputy general manager of Harbin Pharmaceutical Group Bioengineering Co., Ltd. from November 1997 to June 2005. He was also the director and general manager of China National Medicines Guorui Pharmaceutical Co., Ltd. from July 2005 to August 2010. He has been the director, general manager and deputy secretary to the Party Committee of China National of Traditional & Herbal Medicine Co., Ltd. (formerly named as China National Corp. of Traditional & Herbal Medicine) since August 2010. He is re-designated from deputy secretary of the Party Committee to secretary of the Party Committee since January 2018.

Min Situ

Mr. Min Situ is Chief Financial Officer of the Company. Mr. SITU previously served in the Board of Wing Shan International Limited and Winteam Pharmaceutical Group Limited from September 2001 to February 2013. He is a fellow member of the Association of Chartered Certified Accountants and is also a member of Chinese Institute of Certified Public Accountants. Mr. SITU has extensive experience in financial management, and corporate finance and acquisitions.

He Huang

Ms. Huang He is the Vice President of the Company. Ms. HUANG graduated from Renmin University of China with a bachelor degree in International Accounting in July 2001 and a master degree in Accounting in July 2004. Ms. HUANG is an auditor and a senior human resources officer. She was the accountant of the finance department, the vice manager of the operation and audit department and the manager of the strategic planning department of Traditional & Herbal Medicine Company from July 2004 to December 2007; the manager of the audit department, the employee supervisor of the board of supervisors and the manager of the human resources department of China National Corporation of Traditional and Herbal Medicine from January 2008 to December 2013; the director of human resources and the manager of the human resources department of China National Traditional Chinese Medicine Corporation from January 2014 to January 2015. Currently, Ms. HUANG is the director of operations and the manager of the human resources department of China National Traditional Chinese Medicine Corporation.

Zhangxin Huang

Mr. Huang Zhangxin is Vice President of the Company. He was appointed as a vice president of the Company in November 2013, in charge of work relating to the production and R&D of the products. Mr. HUANG has engaged in management of drug research and development, manufacturing and sales business for over 20 years. He served as director of Research and Development, assistant to general manager and deputy general manager of Winteam Pharmaceutical Group Limited; deputy general manager of Guangdong Medi-World Pharmaceutical Co., Ltd., and deputy general manager of Shunde Nanfang Bio-Pharmaceutical Co., Ltd. Mr. HUANG obtained the qualification of pharmaceutical engineer, and was awarded as Foshan City Advanced Innovation Character third prize and Shunde Technology Progress second prize.

Qingsheng Zhang

Mr. Zhang Qingsheng is Vice President of the Company. He was appointed as a vice president of the Company in July 2013, and the party secretary of the Company in October 2013 respectively. Mr. ZHANG has over 30 years of working experience, and he currently takes charge of the party committee, human resources and assist the Managing Director on investing activities management. Mr. ZHANG has served as several positions including vice president, director, chairman of the labor union and secretary of the board of directors of China National Corp. of Traditional & Herbal Medicines (currently known as China National Traditional Chinese Medicine Corporation) from 2005 to 2013.

Xiaochun Wang

Mr. Wang Xiaochun is Managing Director, Executive Director of Winteam Pharmaceutical Group Limited. Mr. Wang was the chairman of the board of directors and the chief executive officer of Tongjitang Chinese Medicines Company, which was listed on the New York Stock Exchange in 2007 and subsequently privatised in 2011. He has been a director of Tongjitang Pharmaceutical (Hong Kong) Limited (a subsidiary of the Tongjitang Chinese Medicines Company) since 2008, a director of Unisources Enterprises Limited (a subsidiary of Tongjitang Chinese Medicines Company) since 2005 and the chairman of the board of directors and the president of Guizhou Tongjitang Pharmaceutical Co., Ltd. (a subsidiary of Tongjitang Chinese Medicines Company) since 1997. Mr. Wang received his bachelor’s degree in law from the Southwest University of Political Science and Law in China in 1989.

Wenming YANG

Mr. YANG Wenming serves as Executive Director of the company. He graduated from Zhejiang University majoring in Biological and Medical Instruments and obtained a bachelor degree of Engineering in 1985. Mr. YANG Wenming also has the senior engineer professional qualification. He was previously a staff member of the quality standard department, a senior staff member, a principal staff member, the deputy department head of the external cooperation department, the assistant of general manager and the department head of the external cooperation department and the assistant of general manager of China National Medical Equipment Industry Corporation from August 1985 to March 1999 and the assistant of the department head of the Medical Equipment Administration Department and a senior staff of the Medical Equipment Products Examination and Registration Centre of the State Medicine Administrative Bureau of China from January 1997 to January 1998. He was previously an office manager, manager of the information department, manager of the discipline inspection and supervision office, manager of the audit department, deputy secretary of discipline inspection committee, vice president of labour union and the staff supervisor of China National Pharmaceutical Group Corporation (“CNPGC”), and deputy general manager, deputy secretary of the Party Committee and secretary of discipline inspection committee, president of labour union of China National Pharmaceutical Industry Company Limited from March 1999 to April 2017; the deputy secretary of the Party Committee, secretary of discipline inspection committee and president of labour union of Shanghai Shyndec Pharmaceutical Co., Ltd. from November 2016 to December 2018. He is currently the staff supervisor of Shanghai Shyndec Pharmaceutical Co., Ltd., the secretary of the Party Committee and vice president of China Traditional Chinese Medicine Holdings Co. Limited.

Suet Lun Leung

Ms. Leung Suet Lun has been appointed as the Joint Company Secretary of the Company. Ms. LEUNG, a manager of the Listing Services Department of TMF Hong Kong Limited, has approximately 8 years of professional experience in the legal, company secretarial and tax consulting fields. She is a member of the Hong Kong Institute of Certified Public Accountants and a solicitor of Hong Kong.

Dongji Zhao

Mr. Zhao Dongji is Joint Company Secretary of the Company. Mr. ZHAO obtained a bachelor’s degree in engineering from Harbin Institute of Technology in 1989, and also obtained a master’s degree in business administration from Harbin Institute of Technology in 2004. Mr. ZHAO has over 26 years of related working experience, including over 15 years of management experience in pharmaceutical and health products industry. Mr. ZHAO acted as the deputy head and head of Enterprise Management Department, head of Asset Management Department and Legal Department of Harbin Pharmaceutical Group Co., Ltd. from 2000 to 2011. He also acted as a director of Harbin Pharm Group Sanjing Pharmaceutical Shareholding Co., Ltd (a company listed on the SSE) from June 2004 to February 2011. Mr. ZHAO has served as the manager of Investment Management Department of China National Traditional Chinese Medicine Corporation (formerly named as China National Corp. of Traditional & Herbal Medicine) since 2011. Mr. ZHAO is the deputy general manager of China National Traditional Chinese Medicine Corporation since November 2014.

Kaipin Kui

Mr. Kui Kaipin is Non-Executive Director of the Company. He graduated from the School of International Liberal Studies of Waseda University with a bachelor’s degree in International Liberal Studies in 2008. He obtained a master’s degree in International Relation from the Graduate School of Asia-Pacific Studies of Waseda University in 2010. Mr. KUI joined Ping An in 2012 and has served various positions in the Ping An Group. He is currently a managing director of the private equity department of China Ping An Insurance Overseas (Holdings) Limited responsible for overseas private equity investments and strategic investments.

Yan Rong

Ms. RONG Yan serves as Non-Executive Director of the company. Ms. Rong Yan has over 28 years of working experience and is currently the director of finance department of CNPGC. Ms. Rong obtained a bachelor degree in Accounting from Liaoning University in July 1991 and a master degree in International Finance and Investment from Derby Business School at University of Derby in the United Kingdom in October 2000. Ms. Rong served as a cadre of the Institute of Intelligence of China National Petroleum Corporation from August 1991 to May 1993, and the financial manager of China Zhenhua Import and Export Corporation from May 1993 to October 2001. Ms. Rong served successively as manager of finance department, deputy chief accountant and manager of finance department, and financial controller of China Pharmaceutical Foreign Trade Corporation from October 2001 to February 2008. Ms. Rong served successively as a principal staff member of finance department and a principal staff member of financial management department of CNPGC from February 2008 to June 2011. Ms. Rong served as Director of China National of Traditional & Herbal Medicine Co., Ltd. from April 2016 to December 2018, non-executive Director of Sinopharm Group Co. Ltd. (Stock Code: 1099) from March 2018 to November 2018. Ms. Rong has been serving as a principal staff member of finance department of CNPGC since June 2011. She has also been serving as financial controller of Sinopharm Investment Co., Ltd. since July 2015, and chairman of Sinopharm Group Finance Co., Ltd. since August 2017.

Kan WANG

Mr. WANG Kan serves as Non-Executive Director of the company. He obtained a bachelor degree in Pharmacy from the School of Pharmacy of Peking University Health Science Center in 2007, a master degree in Pharmacy from the School of Pharmacy of Peking University Health Science Center and double bachelor degree of Economics from China Center for Economic Research of Peking University in 2009. Mr. WANG was a staff member of planning development and industrial management department of China National Pharmaceutical Industry Company Limited from August 2009 to May 2010; a staff member of the investment management department and securities department of China National Biotech Group Company Limited from May 2010 to November 2014; and a senior business executive and assistant of manager of the investment management department of CNPGC from November 2014 to January 2018. He has also been a director of Suzhou Capsugel Co., Ltd. in March 2018. He is currently the deputy manager of the investment management department of CNPGC.

Binghua YANG

Mr. YANG Binghua serves as Non-Executive Director of the company. He obtained a bachelor degree in Politics and Administration of Public Administration from China Youth University for Political Sciences in 2004 and obtained a master degree in Public Administration from School of Government of Peking University in 2011. He was previously a staff member, a senior staff member and a principal staff member of the information research office of the State Council State-owned Assets Supervision and Administration Commission (“SASAC”) Office from July 2004 to December 2013; person-incharge of the basic training programme of Daqing Oilfield production plant No.2 from April 2010 to March 2011; person-in-charge of the basic training programme of the governmental and enterprises customers division of China Telecom from August 2012 to December 2013; the deputy department head of the second secretarial department, a senior staff of the department party committee office, the deputy department head of the promotional department of the department party committee and the department head of the promotional department of the department party committee of the State Council SASAC Office from December 2013 to March 2017. In which, he served as a staff member of the management enhancement group office of asset committee authorities. He was previously a cadre of department of party-masses relationship, a senior staff member of department of party-masses relationship and a senior staff member of department of party-masses relationship of CNPGC from March 2017 to May 2018. He has been a director of China National Traditional Chinese Medicine Co., Ltd. in March 2018. He is currently a principal staff of department of party-masses relationship of CNPGC.

Shanhua Yang

Mr. Yang Shanhua is Non-Executive Director of the Company. Mr. YANG graduated from Southwestern University of Finance and Economics in 1993, with a master degree in accounting major and he obtained a doctoral degree in accounting from Chinese Academy of Fiscal Science in 2005. He is a senior accountant. Mr. YANG was chief financial officer and manager of financial department in Beijing Oriental Yuhong Waterproof Technology Co., Ltd, chief accountant in China National Biotec Group Company Limited, deputy general manager in China National Pharmaceutical Group Corporation, one after another, from June 2000 to May 2017. He is currently the chief accountant of China National Pharmaceutical Group Corporation.

Wing Yat Lo

Mr. Lo Wing Yat (Kelvin)is Non-Executive Independent Director of Winteam Pharmaceutical Group Ltd. Mr. LO is an executive director of FDG Electric Vehicles Limited (Stock Code: 729) and has been an executive director of FDG Kinetic Limited (formerly known as CIAM Group Limited (Stock Code: 378) from April 2008 to March 2016, both shares are listed on the Stock Exchange. He is also a director and the Chief Executive Officer of both CITIC International Assets Management Limited and CITIC International Financial Holdings Limited. Mr. LO graduated from the University of Hong Kong with a bachelor’s degree in Laws. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1984 and a solicitor of the Supreme Court of England and Wales in 1989. He served as an in-house counsel of Bank of China Hong Kong-Macau Regional Office and a partner of Linklaters. During his legal career, Mr. LO was specialized in banking project financing primarily in the PRC.

Rong Xie

Mr. Xie Rong has been appointed as Non-Executive Independent Director of Winteam Pharmaceutical Group Ltd., effective February 5, 2013. Mr. XIE has over 49 years of working experience. He obtained a doctorate degree in economics, majoring in accounting from Shanghai University of Finance and Economics, in January 1993. He was the deputy head of the Accounting Department of Shanghai University of Finance and Economics and a partner of KPMG China (Shanghai) from September 1994 to November 1997 and from December 1997 to October 2002, respectively. Mr. XIE has been a director of SAIC Motor Corporation Limited (a company listed on the SSE) since April 2003 and was its independent director from April 2003 to June 2008. Mr. Xie was an independent non-executive director of each of China Shipping Development Company Limited (a company listed on the Stock Exchange and the SSE), China Eastern Airlines Corporation Limited (a company listed on the Stock Exchange and the SSE), China CITIC Bank Corporation Limited (a company listed on the Stock Exchange and the SSE), Tianjin Capital Environmental Protection Group Company Limited (a company listed on the Stock Exchange and the SSE), Sinopharm Group Co., Ltd. (a company listed on the Stock Exchange) and Shanghai Baosight Software Co., Ltd. (a company listed on the SSE) from May 2003 to May 2009, from June 2003 to May 2010, from February 2007 to October 2012, from April 2008 to April 2014, from August 2007 to September 2014 and from April 2010 to April 2016 respectively. Mr. XIE has been an independent non-executive director of each of China Everbright Bank Company Limited (a company listed on the Stock Exchange and the SSE) and Shenwan Hongyuan Group Co., Ltd. (a company listed on the Shenzhen Stock Exchange) since January 2013 and January 2015, respectively. Mr. XIE was the vice-president of the Shanghai National Accounting Institute from October 2002 to August 2012 and is currently a professor of the Shanghai National Accounting Institute.

Tze Shan Yu

Mr. Yu Tze Shan (Hailson) is Independent Non-Executive Director of China Traditional Chinese Medicine Co. Limited., since November 25, 2013. Upon completing the Electrical Engineering Degree in 1979, Mr. YU worked as an assistant engineer in Ampex Ferrotec Limited After three years, he became the manager of equipment maintenance and testing laboratory and subsequently managed the computer engineering and system engineering team for product and system design, product development plan and the establishment of CAD center. In 1987, Mr. YU joined China International Trust and Investment Corporation Hong Kong (Holdings) Limited as a general manager of engineering research and development department. During such period, he improved the business of subsidiaries engaged in technology sector and monitored the venture capital operation in respect of the high-technology business of the U.S. company. He also made contribution to the successful listing of two subsidiaries in the U.S. and the asset trading of several subsidiaries and later became the consultant for oil development and LPG terminal project. Since 1998, Mr. YU has been a deputy managing director of Versitech Limited and deputy director of Technology Transfer Office of the University of Hong Kong, a technology transfer and commercial company of The University of Hong Kong which mainly commercializes and transfers achievements in scientific research to the business sectors. Additional, Mr. YU has been an independent non-executive director of Sinopharm Group Co., Ltd. (a company listed on the Stock Exchange) since September 2014. Mr. YU also serves as an independent non-executive director of China NT Pharma Group Company Limited since June 2017. Mr. YU possesses bachelor’s and master’s degree in Electrical Engineering and a master of arts degree in Arbitration and Dispute Resolution.

Bajun Zhou

Mr. Zhou Bajun has been appointed as Non-Executive Independent Director of Winteam Pharmaceutical Group Ltd., effective February 5, 2013. Mr. ZHOU obtained a doctorate degree in economics from East China Normal University in October 1988. Mr. ZHOU has over 30 years of working experience, including over 20 years working experiences in Hong Kong’s financial market or China’s securities market. Mr. ZHOU worked in Sun Hung Kai Financial Group as head of China Business and Director of China Studies from November 1990 to November 1998. Mr. ZHOU worked as deputy general manager of the China Business Department of Hong Kong Construction (Hong Kong) Limited from March 1999 to February 2000 and was in charge of the development of Yangpu, Hainan, and has been a director of China Everbright Research Limited since March 2000 to June 2014. Since February 2002 to present, he has been senior research fellow of China Everbright Holdings Company Limited. Mr. ZHOU was a member of the Commission on Strategic Development of the Hong Kong Special Administrative Region from November 2005 to June 2012. He was a visiting professor of School of Business, Hong Kong Baptist University from October 2007 to August 2009. He has been a standing commissioner of the Hong Kong and Macau Research Center of Shanghai Academy of Social Science since March 2007. Mr. ZHOU has served as an independent non-executive director of Sinopharm Group Co., Ltd. (a company listed on the Stock Exchange) since August 2009 to September 2014.

Eileen Wang

Basic Compensation